HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NNC 26-9100

structure in first source

Also Known As:

NNC-26-9100

Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Banks, William A: 1 article (03/2011)
2.	Crider, Albert M: 1 article (03/2011)
3.	Farr, Susan A: 1 article (03/2011)
4.	Morley, John E: 1 article (03/2011)
5.	Niehoff, Michael L: 1 article (03/2011)
6.	Sandoval, Karin E: 1 article (03/2011)
7.	Witt, Ken A: 1 article (03/2011)

Related Diseases

1.	Glaucoma 11/19/1998 - "Studies are currently in progress to evaluate the therapeutic potential of NNC 26-9100 (11) in the treatment of glaucoma."
2.	Alzheimer Disease (Alzheimer's Disease) 03/01/2011 - "The second goal of this study was to evaluate the effect of chronic NNC 26-9100 administration (i.p.) on learning and memory, brain Aβ(x-42) levels, and protein expression of sst4 receptor and amyloid precursor protein (APP) in the senescence-accelerated mouse p8 (SAMP8) model of Alzheimer's disease. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Amyloid (Amyloid Fibrils)
3.	somatostatin receptor subtype-4